GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast AS (OTCPK:CLPBY) » Definitions » Gross Margin %

CLPBY (Coloplast AS) Gross Margin % : 66.73% (As of Sep. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Coloplast AS Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Coloplast AS's Gross Profit for the three months ended in Sep. 2024 was $691 Mil. Coloplast AS's Revenue for the three months ended in Sep. 2024 was $1,035 Mil. Therefore, Coloplast AS's Gross Margin % for the quarter that ended in Sep. 2024 was 66.73%.


The historical rank and industry rank for Coloplast AS's Gross Margin % or its related term are showing as below:

CLPBY' s Gross Margin % Range Over the Past 10 Years
Min: 66.64   Med: 68.05   Max: 68.78
Current: 67.59


During the past 13 years, the highest Gross Margin % of Coloplast AS was 68.78%. The lowest was 66.64%. And the median was 68.05%.

CLPBY's Gross Margin % is ranked better than
73.29% of 805 companies
in the Medical Devices & Instruments industry
Industry Median: 51.89 vs CLPBY: 67.59

Coloplast AS had a gross margin of 66.73% for the quarter that ended in Sep. 2024 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Coloplast AS was -0.20% per year.


Coloplast AS Gross Margin % Historical Data

The historical data trend for Coloplast AS's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coloplast AS Gross Margin % Chart

Coloplast AS Annual Data
Trend Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 68.01 68.53 68.78 66.64 67.59

Coloplast AS Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 66.37 68.18 67.98 67.51 66.73

Competitive Comparison of Coloplast AS's Gross Margin %

For the Medical Instruments & Supplies subindustry, Coloplast AS's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Coloplast AS's Gross Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Coloplast AS's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Coloplast AS's Gross Margin % falls into.



Coloplast AS Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Coloplast AS's Gross Margin for the fiscal year that ended in Sep. 2024 is calculated as

Gross Margin % (A: Sep. 2024 )=Gross Profit (A: Sep. 2024 ) / Revenue (A: Sep. 2024 )
=2719.4 / 4023.519
=(Revenue - Cost of Goods Sold) / Revenue
=(4023.519 - 1304.108) / 4023.519
=67.59 %

Coloplast AS's Gross Margin for the quarter that ended in Sep. 2024 is calculated as


Gross Margin % (Q: Sep. 2024 )=Gross Profit (Q: Sep. 2024 ) / Revenue (Q: Sep. 2024 )
=690.7 / 1034.981
=(Revenue - Cost of Goods Sold) / Revenue
=(1034.981 - 344.299) / 1034.981
=66.73 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Coloplast AS  (OTCPK:CLPBY) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Coloplast AS had a gross margin of 66.73% for the quarter that ended in Sep. 2024 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Coloplast AS Gross Margin % Related Terms

Thank you for viewing the detailed overview of Coloplast AS's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Coloplast AS Business Description

Address
Holtedam 1-3, Humlebaek, DNK, DK-3050
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Coloplast AS Headlines

From GuruFocus

Q3 2023 Coloplast A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q4 2021 Coloplast A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q3 2024 Coloplast A/S Earnings Call Transcript

By GuruFocus Research 08-21-2024

Q1 2021 Coloplast A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Q4 2024 Coloplast A/S Earnings Call Transcript

By GuruFocus News 11-06-2024

Q4 2020 Coloplast A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024

Coloplast A/S's Dividend Analysis

By GuruFocus Research 05-17-2024

Q2 2024 Coloplast A/S Earnings Call Transcript

By GuruFocus Research 05-08-2024

Q3 2021 Coloplast A/S Earnings Call Transcript

By GuruFocus Research 02-13-2024